ClinicalTrials.govpublic full text
BIOLUMA: Biomarkers for Nivolumab and Ipilimumab and Evaluation of the Combination in Lung Cancer
carcinoma, non-small-cell lung, carcinoma, small cell lung, nivolumab, ipilimumab, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 831724
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.